// App-Quantinova.ai

515 : HER2 gene amplification testing by fluorescence in situ hybridization (FISH): Comparison of the ASCO-CAP guidelines with FISH scores used for enrollment in breast cancer international research group (BCIRG) clinical trials.

Researchers

Presenter

  • Michael F. Press

Principal Investigators

  • Marc E. Buyse

  • Helene Fourmanoir

  • Emmanuel Quinaux

  • Denice D. Tsao-Wei

  • Wolfgang Eiermann

  • Nicholas J. Robert

  • Tadeusz Pienkowski

  • John Crown

  • Miguel Martin

  • Vicente Valero

  • John Robert Mackey

  • Valerie Bee-Munteanu

  • Yanling Ma

  • Ivonne Villalobos

  • Anaamika Campeau

  • Martina Mirlacher

  • Mary-Ann Lindsay

  • Dennis J. Slamon

Medical Centers

  • University of Southern California, Los Angeles, CA

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • International Drug Development Institute, Cambridge, MA

  • International Drug Development Institute, Louvain-La-Neuve, Belgium

  • International Drug Development Institute, Louvain-La-Neuve, Belgium

  • USC Norris Comprehensive Cancer Center, Los Angeles, CA

  • Red Cross Women Hospital, Muenchen, Germany

  • The US Oncology Network, Fairfax, VA

  • Postgraduate Medical Center, Warsaw, Poland

  • Irish Cooperative Oncology Research Group, Dublin, Ireland

  • Hospital Universitario Quiron Madrid, Madrid, Spain

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Cross Cancer Institute, Edmonton, AB, Canada

  • CIRG, Paris, France

  • Department of Pathology, University of Southern California, Los Angeles, CA

  • USC Norris Comprehensive Cancer Center, Los Angeles, CA

  • University of Hamburg, Hamburg, Germany

  • Cancer International Research Group/Translational Research in Oncology, Edmonton, AB, Canada

  • School of Medicine/Translational Oncology Research Laboratory, University of California, Los Angeles, Los Angeles, CA

Locations

  • Ireland

  • Canada

  • Poland

  • Germany

  • Spain

  • United States

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved